Tag: Richard A. Van Etten
-
Nation & World
Resistance mutation found for Gleevec
The drug Gleevec was stunningly successful in treating patients with chronic myelogenous leukemia (CML) at early stages of disease, but quickly stopped working in most patients with more advanced forms…